Safety and Efficacy of Lansoprazole in Patients With Reflux Disease

NCT01135368 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

506

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastroesophageal Reflux

Interventions

DRUG: Lansoprazole

Sponsor

Takeda